HB 112 Summary

• Reduces Board of Pharmacy public members from two to one, maintaining five pharmacists, one pharmacy technician, and one public member for a seven-member board.

• Transfers authority for epinephrine auto-injector training program approval from the Department of Health to the Board of Pharmacy, and allows pharmacists to independently administer epinephrine and prescribe auto-injectors to trained individuals.

• Changes wholesale drug distributor licensing from registration to licensure requirements and expands board authority to regulate manufacturers and distributors of drugs and devices.

• Allows wholesale drug distributors to dispense dialysate drugs and devices directly to end-stage renal disease patients under specified conditions including pharmacist consultation and monthly audits.

• Removes the good moral character requirement for pharmacist licensure by transfer and eliminates ampule-based epinephrine training program provisions, focusing solely on auto-injector training.